U.S. pharma big copyright scrapped two experimental weight loss capsules last yr—a at the time-every day tablet, lotiglipron, on account of elevated liver enzymes along with a 2 times-every day capsule, danuglipron, on account of strong Negative effects—but CEO Albert Bourla has said the company is determined to “Enjoy and win” in the being